Genmark Diagnostics (GNMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,558 | -23,970 | -18,534 | -12,222 | -6,642 |
| Depreciation Amortization | 264 | 1,326 | 948 | 622 | 289 |
| Accounts receivable | 72 | -420 | -117 | -34 | -37 |
| Accounts payable and accrued liabilities | -112 | 378 | 510 | 1,443 | 668 |
| Other Working Capital | -44 | 1,041 | 1,439 | 2,185 | 2,837 |
| Other Operating Activity | -118 | 2,431 | 1,745 | 13 | -205 |
| Operating Cash Flow | $-5,496 | $-19,214 | $-14,009 | $-7,993 | $-3,090 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,000 | -5,000 | -5,000 | N/A | N/A |
| PPE Investments | -17 | -1,376 | -1,172 | -609 | -185 |
| Purchase Sale Intangibles | -739 | -734 | -728 | -365 | N/A |
| Other Investing Activity | -739 | -734 | -728 | -365 | 0 |
| Investing Cash Flow | $4,244 | $-7,110 | $-6,900 | $-974 | $-185 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 2,000 | 2,000 | 2,000 | 2,000 |
| Debt Repayment | -267 | -417 | -167 | N/A | N/A |
| Common Stock Issued | N/A | 34,533 | 34,532 | 34,532 | N/A |
| Other Financing Activity | 0 | -2,854 | -2,790 | -2,377 | 0 |
| Financing Cash Flow | $-267 | $33,262 | $33,575 | $34,155 | $2,000 |
| Exchange Rate Effect | N/A | 53 | 6 | N/A | N/A |
| Beginning Cash Position | 25,320 | 18,329 | 18,329 | 18,329 | 18,329 |
| End Cash Position | 23,801 | 25,320 | 31,001 | 43,517 | 17,054 |
| Net Cash Flow | $-1,519 | $6,991 | $12,672 | $25,188 | $-1,275 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,496 | -19,214 | -14,009 | -7,993 | -3,090 |
| Capital Expenditure | -17 | -1,376 | -1,172 | -609 | -185 |
| Free Cash Flow | -5,513 | -20,590 | -15,181 | -8,602 | -3,275 |